Not for human consumption or administration
The 29 gauge needle is tiny and no discomfort experienced during the subcutaneous injections
Always consult with a healthcare provider before starting any new peptide therapy, as these compounds can have powerful effects and may interact with other medications or treatments
As an NNMT inhibitor, it is associated with reduced white adipose tissue, improved NAD+ availability, and support for insulin sensitivity
Similarly, a pilot study in 2015, a clinical trial (randomised) on 42 healthy human participants, receiving oral (tablet form) dosages of BPC 157 was carried out (Clinicaltrials.gov 2018): 0.25, 0.5, 1 and 2 g/kg
It is sold exclusively for scientific laboratory research and is not intended for human or animal consumption